Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125105882 | 12510588 | 2 | F | 20160615 | 20160729 | 20160629 | 20160805 | EXP | CA-PFIZER INC-2016316088 | PFIZER | 55.00 | YR | M | Y | 0.00000 | 20160805 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125105882 | 12510588 | 1 | PS | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 4 MG FOR 1 HOUR | 74598 | 4 | MG | ||||||||
| 125105882 | 12510588 | 2 | SS | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 3 MG, EVERY (Q) 30 MIN | 74598 | 3 | MG | ||||||||
| 125105882 | 12510588 | 3 | SS | TREMELIMUMAB | TREMELIMUMAB | 1 | Intravenous (not otherwise specified) | 75 MG, MONTHLY | 75 | MG | 0 | 75 | MG | /month | |||||
| 125105882 | 12510588 | 4 | SS | FENTANYL. | FENTANYL | 1 | Transdermal | 50 UG, CYCLIC (EVERY 72 HOURS (Q72H)) | 0 | 50 | UG | TRANSDERMAL PATCH | |||||||
| 125105882 | 12510588 | 5 | SS | MEDI4736 | DURVALUMAB | 1 | Intravenous (not otherwise specified) | 1500 MG, MONTHLY | 1500 | MG | 0 | 1500 | MG | INJECTION | /month | ||||
| 125105882 | 12510588 | 6 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | CAPSULE | BID | ||||||
| 125105882 | 12510588 | 7 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 125105882 | 12510588 | 8 | C | CELECOXIB. | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY | 0 | 200 | MG | TABLET | QD | ||||||
| 125105882 | 12510588 | 9 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 2 TABLESPOONS, DAILY | 0 | 2 | DF | ||||||||
| 125105882 | 12510588 | 10 | C | SENEKOT | 2 | Oral | 10 MG, AS REQUIRED | 0 | 10 | MG | TABLET | ||||||||
| 125105882 | 12510588 | 11 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | 7.5 MG, AS REQUIRED | 0 | 7.5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125105882 | 12510588 | 1 | Bone pain |
| 125105882 | 12510588 | 3 | Squamous cell carcinoma of head and neck |
| 125105882 | 12510588 | 4 | Bone pain |
| 125105882 | 12510588 | 5 | Squamous cell carcinoma of head and neck |
| 125105882 | 12510588 | 6 | Anxiety |
| 125105882 | 12510588 | 7 | Nausea |
| 125105882 | 12510588 | 8 | Pain |
| 125105882 | 12510588 | 9 | Constipation |
| 125105882 | 12510588 | 10 | Constipation |
| 125105882 | 12510588 | 11 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125105882 | 12510588 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125105882 | 12510588 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125105882 | 12510588 | 1 | 20160401 | 0 | ||
| 125105882 | 12510588 | 2 | 20160401 | 0 | ||
| 125105882 | 12510588 | 3 | 20160510 | 20160510 | 0 | |
| 125105882 | 12510588 | 4 | 201505 | 0 | ||
| 125105882 | 12510588 | 5 | 20160510 | 20160510 | 0 | |
| 125105882 | 12510588 | 6 | 20160508 | 0 | ||
| 125105882 | 12510588 | 7 | 20160520 | 0 | ||
| 125105882 | 12510588 | 8 | 20160421 | 0 | ||
| 125105882 | 12510588 | 9 | 20160418 | 0 | ||
| 125105882 | 12510588 | 10 | 201509 | 0 | ||
| 125105882 | 12510588 | 11 | 20160427 | 0 |